Literature DB >> 26079129

Significant association between rare IPO11-HTR1A variants and attention deficit hyperactivity disorder in Caucasians.

Lingjun Zuo1, Laura Saba2, Xiandong Lin3, Yunlong Tan4, Kesheng Wang5, John H Krystal1,6, Boris Tabakoff2, Xingguang Luo1,4.   

Abstract

We comprehensively examined the rare variants in the IPO11-HTR1A region to explore their roles in neuropsychiatric disorders. Five hundred seventy-three to 1,181 rare SNPs in subjects of European descent and 1,234-2,529 SNPs in subjects of African descent (0 < minor allele frequency (MAF) < 0.05) were analyzed in a total of 49,268 subjects in 21 independent cohorts with 11 different neuropsychiatric disorders. Associations between rare variant constellations and diseases and associations between individual rare variants and diseases were tested. RNA expression changes of this region were also explored. We identified a rare variant constellation across the entire IPO11-HTR1A region that was associated with attention deficit hyperactivity disorder (ADHD) in Caucasians (T5: P = 7.9 × 10(-31) ; Fp: P = 1.3 × 10(-32) ), but not with any other disorder examined; association signals mainly came from IPO11 (T5: P = 3.6 × 10(-10) ; Fp: P = 3.2 × 1 0(-10) ) and the intergenic region between IPO11 and HTR1A (T5: P = 4.1 × 10(-30) ; Fp: P = 5.4 × 10(-32) ). One association between ADHD and an intergenic rare variant, i.e., rs10042956, exhibited region- and cohort-wide significance (P = 5.2 × 10(-6) ) and survived correction for false discovery rate (q = 0.006). Cis-eQTL analysis showed that, 29 among the 41 SNPs within or around IPO11 had replicable significant regulatory effects on IPO11 exon expression (1.5 × 10(-17) ≤P < 0.002) in human brain or peripheral blood mononuclear cell tissues. We concluded that IPO11-HTR1A was a significant risk gene region for ADHD in Caucasians.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADHD; IPO11; non-coding RNA; rare variant constellations

Mesh:

Substances:

Year:  2015        PMID: 26079129      PMCID: PMC4851708          DOI: 10.1002/ajmg.b.32329

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  52 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  [Influence of impulsivity, suicidality and serotonin genes on treatment outcomes in alcohol dependence].

Authors:  Marcin Wojnar; Kirk J Brower; Andrzej Jakubczyk; Izabela Zmigrodzka; Margit Burmeister; Halina Matsumoto; Elzbieta Woźny; Elzbieta Sliwerska; Andrea M Hegedus; Anna Husar; Anna Slufarska; Michał Lipiński; Robert A Zucker
Journal:  Psychiatr Pol       Date:  2006 Sep-Oct       Impact factor: 1.657

Review 3.  Emerging roles for the Ro 60-kDa autoantigen in noncoding RNA metabolism.

Authors:  Soyeong Sim; Sandra L Wolin
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-04-21       Impact factor: 9.957

4.  The family based association test method: strategies for studying general genotype--phenotype associations.

Authors:  S Horvath; X Xu; N M Laird
Journal:  Eur J Hum Genet       Date:  2001-04       Impact factor: 4.246

5.  Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD).

Authors:  Martin D Ohlmeier; Karsten Peters; Andreas Kordon; Jürgen Seifert; Bert Te Wildt; Birgitt Wiese; Marc Ziegenbein; Hinderk M Emrich; Udo Schneider
Journal:  Alcohol Alcohol       Date:  2007-08-31       Impact factor: 2.826

6.  The Ro autoantigen binds misfolded U2 small nuclear RNAs and assists mammalian cell survival after UV irradiation.

Authors:  Xinguo Chen; James D Smith; Hong Shi; Derek D Yang; Richard A Flavell; Sandra L Wolin
Journal:  Curr Biol       Date:  2003-12-16       Impact factor: 10.834

7.  The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients.

Authors:  Y Suzuki; K Sawamura; T Someya
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

8.  Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.

Authors:  Britta Haenisch; Karoline Linsel; Michael Brüss; Ralf Gilsbach; Peter Propping; Markus M Nöthen; Marcella Rietschel; Rolf Fimmers; Wolfgang Maier; Astrid Zobel; Susanne Höfels; Vera Guttenthaler; Manfred Göthert; Heinz Bönisch
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

9.  SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

Authors:  Sandra M Villafuerte; Kamala Vallabhaneni; Elzbieta Sliwerska; Francis J McMahon; Elizabeth A Young; Margit Burmeister
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

10.  Clinical manifestation of alcohol withdrawal symptoms related to genetic polymorphisms of two serotonin receptors and serotonin transporter.

Authors:  Young-Sik Lee; Sam-Wook Choi; Doug-Hyun Han; Dai-Jin Kim; Keun-Ho Joe
Journal:  Eur Addict Res       Date:  2008-12-02       Impact factor: 3.015

View more
  2 in total

1.  Network and pathway enrichment analysis of Attention Deficit/Hyperactivity Disorder candidate genes.

Authors:  Pratichi Singh
Journal:  Indian J Psychiatry       Date:  2020-07-27       Impact factor: 1.759

Review 2.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.